These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8923809)

  • 1. Tetramethylpyrazine, a calcium antagonist.
    Pang PK; Shan JJ; Chiu KW
    Planta Med; 1996 Oct; 62(5):431-5. PubMed ID: 8923809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of tetramethylpyrazine on rabbit basilar artery ring and canine vertebroarterial circulation].
    Lü AG; Ke J; Zhang GQ
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):524-6. PubMed ID: 1302440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus.
    Wang GJ; Shum AY; Lin YL; Liao JF; Wu XC; Ren J; Chen CF
    J Pharmacol Exp Ther; 2001 Apr; 297(1):240-6. PubMed ID: 11259550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation effect of a novel Danshensu/tetramethylpyrazine derivative on rat mesenteric arteries.
    Li RW; Yang C; Shan L; Zhang Z; Wang Y; Kwan YW; Lee SM; Hoi MP; Chan SW; Cheung AC; Cheung KH; Leung GP
    Eur J Pharmacol; 2015 Aug; 761():153-60. PubMed ID: 25952729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of calcium entry blockers.
    Godfraind T
    Fed Proc; 1981 Dec; 40(14):2866-71. PubMed ID: 7308497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage-dependent Ca channel?
    Kwan CY; Daniel EE; Chen MC
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):157-62. PubMed ID: 1688974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hypertensive factor inhibits voltage-gated K+ channels in vascular smooth muscle cells.
    Ren J; Zhang L; Benishin CG
    Can J Physiol Pharmacol; 1999 Nov; 77(11):860-5. PubMed ID: 10593658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of osthole inhibition of vascular Ca(v)1.2 current.
    Fusi F; Sgaragli G; Ha le M; Cuong NM; Saponara S
    Eur J Pharmacol; 2012 Apr; 680(1-3):22-7. PubMed ID: 22329900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: differences related to site of origin.
    Sunman W; Martin G; Hair WM; Sever PS; Hughes AD
    J Hum Hypertens; 1993 Apr; 7(2):189-91. PubMed ID: 8389874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived drugs acting on cellular Ca2+ mobilization in vascular smooth muscle: tetramethylpyrazine and tetrandrine.
    Kwan CY
    Stem Cells; 1994 Jan; 12(1):64-7. PubMed ID: 8142921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of protein kinase C-mediated phosphorylation of type III inositol 1, 4, 5-triphosphate receptor in cholecystokinin octapeptide induced calcium mobilization in gastric antral smooth muscle cells].
    Si XM; Huang L; Luo HS; Paul SC; Lü P
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):664-9. PubMed ID: 17553302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium kinetics and effects of calcium antagonist on vascular smooth muscle].
    Aoki K; Miyagawa K
    Nihon Rinsho; 1989 Aug; 47(8):1746-52. PubMed ID: 2585737
    [No Abstract]   [Full Text] [Related]  

  • 16. Kavain attenuates vascular contractility through inhibition of calcium channels.
    Martin HB; McCallum M; Stofer WD; Eichinger MR
    Planta Med; 2002 Sep; 68(9):784-9. PubMed ID: 12357387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle calcium channels.
    van Breemen C; Cauvin C; Yamamoto H; Zschauer A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S10-6. PubMed ID: 2455103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of contractility and the role of Na/Ca exchange in arterial smooth muscle.
    Ashida T; Blaustein MP
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S65-7. PubMed ID: 2455143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-independent vasorelaxation by Ligusticum wallichii in isolated rat aorta: comparison of a butanolic fraction and tetramethylpyrazine, the main active component of Ligusticum wallichii.
    Kim EY; Kim JH; Rhyu MR
    Biol Pharm Bull; 2010; 33(8):1360-3. PubMed ID: 20686232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.